» Articles » PMID: 20180049

Progress and Promise Towards Safe Induced Pluripotent Stem Cells for Therapy

Overview
Publisher Springer
Specialty Cell Biology
Date 2010 Feb 25
PMID 20180049
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides an invaluable resource for drug or toxicology screening, medical research, and patient-specific cell therapy. However, there are currently a number of obstacles including virus integration and the genetic alteration of iPSCs that will need to be overcome before these cells may be considered safe for clinical applications. Here, we highlight the potential and challenges of iPSC research and review advances in reprogramming methods that have rapidly moved the field closer to realizing the goal of generating safe iPSCs for transplantation.

Citing Articles

Bioactive materials for sweat gland regeneration.

Yang X, Xiong M, Fu X, Sun X Bioact Mater. 2023; 31:247-271.

PMID: 37637080 PMC: 10457517. DOI: 10.1016/j.bioactmat.2023.07.025.


TGFβ superfamily signaling regulates the state of human stem cell pluripotency and capacity to create well-structured telencephalic organoids.

Watanabe M, Buth J, Haney J, Vishlaghi N, Turcios F, Elahi L Stem Cell Reports. 2022; 17(10):2220-2238.

PMID: 36179695 PMC: 9561534. DOI: 10.1016/j.stemcr.2022.08.013.


Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System.

Jazaeri F, Sheibani M, Nezamoleslami S, Moezi L, Dehpour A Iran J Pharm Res. 2021; 20(2):1-21.

PMID: 34567142 PMC: 8457732. DOI: 10.22037/ijpr.2020.113362.14254.


An Insight into Reprogramming Barriers to iPSC Generation.

Haridhasapavalan K, Raina K, Dey C, Adhikari P, Thummer R Stem Cell Rev Rep. 2019; 16(1):56-81.

PMID: 31758374 DOI: 10.1007/s12015-019-09931-1.


Direct reprogramming and biomaterials for controlling cell fate.

Kim E, Tae G Biomater Res. 2016; 20:39.

PMID: 27980804 PMC: 5142385. DOI: 10.1186/s40824-016-0086-y.


References
1.
Brons I, Smithers L, Trotter M, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes S . Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007; 448(7150):191-5. DOI: 10.1038/nature05950. View

2.
Minami T, Horiuchi K, Miura M, Abid M, Takabe W, Noguchi N . Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem. 2004; 279(48):50537-54. DOI: 10.1074/jbc.M406454200. View

3.
Ding S, Wu X, Li G, Han M, Zhuang Y, Xu T . Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell. 2005; 122(3):473-83. DOI: 10.1016/j.cell.2005.07.013. View

4.
Shao L, Feng W, Sun Y, Bai H, Liu J, Currie C . Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res. 2009; 19(3):296-306. PMC: 2821711. DOI: 10.1038/cr.2009.20. View

5.
Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K . Induced pluripotent stem cells generated without viral integration. Science. 2008; 322(5903):945-9. PMC: 3987909. DOI: 10.1126/science.1162494. View